Armitage-Doll two-stage model: implications and extension.

The objective of this paper is twofold: (1) to provide insight on the simplified MVK model of carcinogenesis (a model proposed by Moolgavkar and colleagues) by revealing the relationship between the Armitage-Doll two-stage model and the simplified MVK model; and (2) to extend the Armitage-Doll two-stage model to one with time-varying (piece-wise constant) parameters. It is shown that the simplified MVK model is a special case of the Armitage-Doll two-stage model, and many applications of the simplified MVK model involving intermittent exposures or exposures to different compounds in different time periods can be derived easily from the Armitage-Doll two-stage model with piece-wise constant parameters. The limitations of the Armitage-Doll two-stage model are discussed.

[1]  P. Armitage,et al.  A Two-stage Theory of Carcinogenesis in Relation to the Age Distribution of Human Cancer , 1957, British Journal of Cancer.

[2]  D Krewski,et al.  Additive and multiplicative relative risk in the two-stage clonal expansion model of carcinogenesis. , 1991, Risk analysis : an official publication of the Society for Risk Analysis.

[3]  C W Chen,et al.  A stochastic two-stage carcinogenesis model: a new approach to computing the probability of observing tumor in animal bioassays. , 1991, Mathematical biosciences.

[4]  W. Tan,et al.  Cancer models: A nonhomogeneous two-stage model of carcinogenesis , 1988 .

[5]  W. Lijinsky,et al.  Polycyclic aromatic hydrocarbons in commercial solvents. , 1961, Toxicology and applied pharmacology.

[6]  S. Moolgavkar,et al.  Biologically based models for cancer risk assessment: a cautionary note. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.

[7]  A. Kopp-Schneider,et al.  The application of a multistage model that incorporates DNA damage and repair to the analysis of initiation/promotion experiments. , 1991, Mathematical biosciences.

[8]  G. Charnley,et al.  Biologically motivated cancer risk models. , 1987, Risk analysis : an official publication of the Society for Risk Analysis.

[9]  S H Moolgavkar,et al.  A stochastic two-stage model for cancer risk assessment. II. The number and size of premalignant clones. , 1989, Risk analysis : an official publication of the Society for Risk Analysis.

[10]  S. Moolgavkar,et al.  Two-event models for carcinogenesis: incidence curves for childhood and adult tumors☆ , 1979 .

[11]  A. Moini,et al.  Cancer Dose-Response Models Incorporating Clonal Expansion , 1990 .

[12]  D. Gaylor,et al.  Using the biological two-stage model to assess risk from short-term exposures. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.

[13]  S H Moolgavkar,et al.  Mutation and cancer: a model for human carcinogenesis. , 1981, Journal of the National Cancer Institute.

[14]  E. Luebeck,et al.  Two-mutation model for carcinogenesis: joint analysis of premalignant and malignant lesions. , 1991, Mathematical biosciences.

[15]  W. Y. Tan,et al.  On the assessment of effects of environmental agents on cancer tumor development by a two-stage model of carcinogenesis , 1985 .

[16]  A Kopp-Schneider,et al.  A multistage model of carcinogenesis incorporating DNA damage and repair. , 1991, Risk analysis : an official publication of the Society for Risk Analysis.